CENTRAL PONTINE MYELINOLYSIS side effect
What is CENTRAL PONTINE MYELINOLYSIS ?Drugs associated with CENTRAL PONTINE MYELINOLYSIS
COPEGUS CORTRIL DACLIZUMAB DEXTROSE INTERFERON NOXAFIL PEGASYSCENTRAL PONTINE MYELINOLYSIS : Dextrose Side Effects Report #5653375-X
Health Professional from UNITED STATES reported DEXTROSE problem on Feb 28, 2008. Male patient, child 4 years of age, was diagnosed with dehydration and was treated with DEXTROSE. After drug was administered, patient experienced the following problems/side effects: central pontine myelinolysis, convulsion, cyanosis, hyponatraemia, pneumonia aspiration, respiratory arrest, unresponsive to stimuli, . DEXTROSE dosage: unknown. Patient recovered.
CENTRAL PONTINE MYELINOLYSIS : Dextrose Side Effects Report #5645274-4
DEXTROSE problem was reported by a Health Professional from UNITED KINGDOM on Feb 21, 2008. Male patient, child 4 years of age, was diagnosed with dehydration and was treated with DEXTROSE. After drug was administered, patient experienced the following problems/side effects: central pontine myelinolysis, hyponatraemia, . DEXTROSE dosage: unknown. Patient recovered.
CENTRAL PONTINE MYELINOLYSIS : Cortril Side Effects Report #5567565-8
Consumer or non-health professional from JAPAN reported CORTRIL problem on Dec 10, 2007. Male patient, weighting 134.5 lb, was diagnosed with hypopituitarism and was treated with CORTRIL. After drug was administered, patient experienced the following problems/side effects: central pontine myelinolysis, . CORTRIL dosage: DAILY DOSE:20MG. During the same period patient was treated with THYRADIN S. Patient was hospitalized and became disabled. Patient recovered.
CENTRAL PONTINE MYELINOLYSIS : Cortril Side Effects Report #5574918-0
CORTRIL problem was reported by a Consumer or non-health professional from JAPAN on Dec 17, 2007. Male patient, weighting 134.5 lb, was diagnosed with secondary adrenocortical insufficiency, hypopituitarism and was treated with CORTRIL. After drug was administered, patient experienced the following problems/side effects: central pontine myelinolysis, . CORTRIL dosage: unknown. During the same period patient was treated with THYRADIN S. Patient was hospitalized and became disabled. Patient recovered.
CENTRAL PONTINE MYELINOLYSIS : Copegus Side Effects Report #5506627-8
Health Professional from UNITED KINGDOM reported COPEGUS problem on Oct 23, 2007. Female patient, 49 years of age, was diagnosed with cryoglobulinaemia and was treated with COPEGUS. After drug was administered, patient experienced the following problems/side effects: central pontine myelinolysis, hepatitis, . COPEGUS dosage: unknown. During the same period patient was treated with PEGASYS, OLANZAPINE, ACETAMINOPHEN, THIAMINE, VITAMIN B CO. Patient was hospitalized. Patient recovered.
CENTRAL PONTINE MYELINOLYSIS : Cortril Side Effects Report #5524345-7
CORTRIL problem was reported by a Consumer or non-health professional from JAPAN on Nov 09, 2007. Male patient, 40 years of age, weighting 134.5 lb, was diagnosed with hypopituitarism and was treated with CORTRIL. After drug was administered, patient experienced the following problems/side effects: central pontine myelinolysis, . CORTRIL dosage: DAILY DOSE:20MG. During the same period patient was treated with LEVOTHYROXINE. Patient recovered.
CENTRAL PONTINE MYELINOLYSIS : Copegus Side Effects Report #5488253-2
Health Professional from UNITED KINGDOM reported COPEGUS problem on Oct 10, 2007. Female patient, 49 years of age, was diagnosed with cryoglobulinaemia and was treated with COPEGUS. After drug was administered, patient experienced the following problems/side effects: central pontine myelinolysis, hepatitis, . COPEGUS dosage: unknown. During the same period patient was treated with PEGASYS, OLANZAPINE, PARACETAMOL, THIAMINE, VITAMIN B CO. Patient was hospitalized. Patient recovered.
CENTRAL PONTINE MYELINOLYSIS : Copegus Side Effects Report #5497280-0
COPEGUS problem was reported by a Health Professional from UNITED KINGDOM on Oct 16, 2007. Female patient, 49 years of age, was diagnosed with hepatitis c and was treated with COPEGUS. After drug was administered, patient experienced the following problems/side effects: central pontine myelinolysis, hepatitis, . COPEGUS dosage: unknown. During the same period patient was treated with PEGASYS, OLANZAPINE, PARACETAMOL, THIAMINE, VITAMIN B CO. Patient was hospitalized. Patient recovered.
CENTRAL PONTINE MYELINOLYSIS : Copegus Side Effects Report #5452928-1
Health Professional from UNITED KINGDOM reported COPEGUS problem on Sept 03, 2007. Female patient, 49 years of age, was diagnosed with hepatitis c virus and was treated with COPEGUS. After drug was administered, patient experienced the following problems/side effects: central pontine myelinolysis, hepatitis, . COPEGUS dosage: unknown. During the same period patient was treated with PEGASYS, OLANZAPINE, PARACETAMOL, THIAMINE, VITAMIN B CO. Patient was hospitalized. Patient recovered.
CENTRAL PONTINE MYELINOLYSIS : Copegus Side Effects Report #5459779-2
COPEGUS problem was reported by a Health Professional from UNITED KINGDOM on Sept 14, 2007. Female patient, 49 years of age, was diagnosed with cryoglobulinaemia and was treated with COPEGUS. After drug was administered, patient experienced the following problems/side effects: central pontine myelinolysis, hepatitis, . COPEGUS dosage: unknown. During the same period patient was treated with PEGASYS, OLANZAPINE, PARACETAMOL, THIAMINE, VITAMIN B CO. Patient was hospitalized. Patient recovered.
CENTRAL PONTINE MYELINOLYSIS : Pegasys Side Effects Report #5471152-X
Health Professional from UNITED KINGDOM reported PEGASYS problem on Sept 14, 2007. Female patient, 49 years of age, was diagnosed with cryoglobulinaemia and was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: central pontine myelinolysis, hepatitis, . PEGASYS dosage: unknown. During the same period patient was treated with RIBAVIRIN. Patient was hospitalized. Patient recovered.
CENTRAL PONTINE MYELINOLYSIS : Pegasys Side Effects Report #5404220-9
PEGASYS problem was reported by a Health Professional from UNITED KINGDOM on July 24, 2007. Female patient, 49 years of age, was diagnosed with cryoglobulinaemia and was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: central pontine myelinolysis, hepatitis, . PEGASYS dosage: unknown. During the same period patient was treated with RIBAVIRIN. Patient was hospitalized. Patient recovered.
CENTRAL PONTINE MYELINOLYSIS : Interferon Side Effects Report #5405244-8
Health Professional from AUSTRALIA reported INTERFERON ALFA problem on July 26, 2007. Male patient, 51 years of age, was diagnosed with hepatitis c and was treated with INTERFERON ALFA. After drug was administered, patient experienced the following problems/side effects: central pontine myelinolysis, cerebellar syndrome, encephalitis, nervous system disorder, reflexes abnormal, transaminases increased, . INTERFERON ALFA dosage: unknown. Patient was hospitalized. Patient recovered.
CENTRAL PONTINE MYELINOLYSIS : Daclizumab Side Effects Report #5391419-3
DACLIZUMAB problem was reported by a Physician from NETHERLANDS on July 11, 2007. Male patient, 67 years of age, was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: central pontine myelinolysis, cerebral hygroma, . DACLIZUMAB dosage: unknown. Patient was hospitalized. Patient recovered.
CENTRAL PONTINE MYELINOLYSIS : Daclizumab Side Effects Report #5391419-3
Physician from NETHERLANDS reported DACLIZUMAB problem on July 11, 2007. Male patient, 67 years of age, was treated with DACLIZUMAB. After drug was administered, patient experienced the following problems/side effects: central pontine myelinolysis, cerebral hygroma, . DACLIZUMAB dosage: unknown. Patient was hospitalized. Patient recovered.
CENTRAL PONTINE MYELINOLYSIS : Noxafil Side Effects Report #5670017-8
NOXAFIL problem was reported by a Physician from SPAIN on Mar 04, 2008. Female patient, 63 years of age, weighting 123.5 lb, was diagnosed with graft versus host disease, transplant and was treated with NOXAFIL. After drug was administered, patient experienced the following problems/side effects: central pontine myelinolysis, quadriparesis, . NOXAFIL dosage: 200 MG; Q8H; PO. During the same period patient was treated with CORTICOSTEROID, CELLCEPT, PREDNISONE, MAGNESIOBOI, SEPTRINTE, ADALAT, APOCARD. Patient was hospitalized. Patient died on 01/24/2008.
CENTRAL PONTINE MYELINOLYSIS : Noxafil Side Effects Report #5648097-5
Physician from SPAIN reported NOXAFIL problem on Feb 21, 2008. Female patient, 63 years of age, weighting 123.5 lb, was diagnosed with transplant and was treated with NOXAFIL. After drug was administered, patient experienced the following problems/side effects: central pontine myelinolysis, coordination abnormal, csf protein increased, paresis, . NOXAFIL dosage: 200 MG;Q8H;PO. During the same period patient was treated with CORTICOSTEROID, CELLCEPT, PREDNISONE, MAGNESIOBOI, SEPTRINTE, ADALAT, APOCARD, OMEPRAZOLE. Patient was hospitalized. Patient died on 01/24/2008.